This website uses cookies to enhance the user experience.
||
UNILABS NORGE AS

UNILABS NORGE AS981 230 787

Laboratory
Limited company
Silurveien 2 0380 OSLO, Norge

UNILABS NORGE AS

Keywords

x-ray institutesblood banks

Links

Organization

Chairman of the board
Years since formation
26 years
since Nov 10, 1999
Type
Limited company
VAT registered
Yes
Number of employees
278

Ownership

Number of shares and share classes
1
1 share class
Total number of shareholders
1
person
Belongs to group of

Financials

Total operating income 2024
635,496,147
NOK
Annual total result 2024
45,010,868
NOK
Total equity 2024
503,475,415
NOK
Last update: Aug 12, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Board Member-
Board Member-
Board Member-
Alternate Member-
Board Member-
Chairman-
Board Member-
Board Member-

Others

NameRoleShares
P
PRICEWATERHOUSECOOPERS AS
Auditor-
Last update: Mar 3, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
1
100 %

Shares owned by the UNILABS NORGE AS

NameShare classTotal number of sharesShare
Ordinary shares
358
100 %
B
BYEN VÅR DRAMMEN AS
Ordinary shares
84
0.24 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2024: NOK 635,496,147
    Operating profit 2024: NOK 85,652,303
    Employees: 278

Financials

in NOK

Summary

Year2024202320222021
Total operating income
635,496,147
607,236,924
602,395,513
578,307,820
Annual Total Result
45,010,868
29,309,675
30,102,173
44,853,387
Total assets
1,288,591,076
1,206,458,774
1,187,297,007
1,193,450,988
Total liabilities
785,115,660
748,039,322
758,069,133
794,168,668
Total equity
503,475,415
458,419,452
429,227,874
399,282,320

P&L

Year2024202320222021
Total operating income
635,496,147
607,236,924
602,395,513
578,307,820
Total operating costs
549,843,844
542,876,675
532,969,511
487,311,423
Operating result
85,652,303
64,360,250
69,426,003
90,996,397
Financial income/costs
-28,037,682
-26,919,016
-31,031,604
-32,762,160
Profit before tax
57,614,621
37,441,233
38,394,398
58,234,238
Total tax & extraordinary income/cost
12,603,753
8,131,558
8,292,225
13,380,851
Annual Total Result
45,010,868
29,309,675
30,102,173
44,853,387

Balance overview

Year2024202320222021
Total fixed assets
783,781,559
809,189,927
820,810,411
862,049,507
Total current assets
504,809,516
397,268,847
366,486,597
331,401,481
Total assets
1,288,591,076
1,206,458,774
1,187,297,007
1,193,450,988
Short term debt
203,874,021
153,662,393
175,581,026
168,355,539
Long term debt
581,241,639
594,376,929
582,488,107
625,813,129
Total liabilities
785,115,660
748,039,322
758,069,133
794,168,668
Contributed capital
381,825,441
381,825,441
381,825,441
381,825,441
Retained earnings
121,649,974
76,594,011
47,402,433
17,456,879
Total equity
503,475,415
458,419,452
429,227,874
399,282,320
Total equity and liabilities
1,288,591,076
1,206,458,774
1,187,297,007
1,193,450,988

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
Q
Main industrial area
Human health and social work activities
86
Activity
Human health activities
86.9
Main industrial group
Other human health activities
86.90
Industrial group
Other human health activities
86.906
Industrial group
Medical laboratories